Answer
Sep 18, 2024 - 12:42 PM
The bioavailability of Trelegy Ellipta is 15.2%. Bioavailability indicates the proportion of the drug that enters the circulation when introduced into the body and is available for therapeutic effect.
Do you have the same question? Follow this Question
Sep 18, 2024 - 12:42 PM
View all Trelegy Ellipta (Fluticasone Furoate / Umeclidinium / Vilanterol Trifenatate) Questions & Answers